Remote modulation of lncRNA <i>GCLET</i> by risk variant at 16p13 underlying genetic susceptibility to gastric cancer.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32671202.
- Also identified by DOI 10.1126/sciadv.aay5525 and PMC identifier 7314563.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The biological effects of susceptibility loci are rarely reported in gastric tumorigenesis. We conducted a large-scale cross-ancestry genetic study in 18,852 individuals and identified the potential causal variant rs3850997 T>G at 16p13 significantly associated with a decreased risk of gastric cancer [odds ratio (OR) = 0.87, 95% confidence interval (CI) = 0.83 to 0.91, <i>P</i> = 2.13 × 10<sup>-9</sup>]. This risk effect was mediated through the mapped long noncoding RNA <i>GCLET</i> (<i>Gastric Cancer Low-Expressed Transcript</i>; OR<sub>indirect</sub> = 0.987, 95% CI = 0.975 to 0.999, <i>P</i> = 0.018). Mechanistically, rs3850997 exerted an allele-specific long-range regulatory effect on <i>GCLET</i> by affecting the binding affinity of CTCF. Furthermore, <i>GCLET</i> increased <i>FOXP2</i> expression by competing with miR-27a-3p, and this regulation remarkably affected in vitro, in vivo, and clinical gastric cancer phenotypes. The findings highlight the genetic functions and implications for the etiology and pathology of cancers.
Medical subject headings
- MicroRNAs
- RNA, Long Noncoding
- Stomach Neoplasms